Singapore O&G (SOG) reported a strong set of Q3 results with the company reporting year on year and quarter on quarter revenue growth.

Q3 revenue was up 18% year on year while net profit grew 23% year on year to SGD2.8 million.

The improved results is especially impressive since it was driven by organic growth and not acquisitions. Existing clinics benefited from a higher patient load  and the ramp-up of two pediatricians who joined in 2017.

Q3 revenue grew 18% year on year and 5% quarter on quarter with growth across its O&G segment (SGD0.8 million), cancer (SGD0.5 million) and paediatrics (SGD0.1 million) segments. The dermatology segment was the only segment which did not grow in Q3 and was hit by a slight SGD0.1 million decline in revenue.

SOG’s share price performance has been weak over the last five months but the company’s prospects remains bright. SOG’s share of Singapore’s private